C. Villena

445 total citations
6 papers, 229 citations indexed

About

C. Villena is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, C. Villena has authored 6 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Cancer Research and 1 paper in Molecular Biology. Recurrent topics in C. Villena's work include HER2/EGFR in Cancer Research (3 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Treatment and Pharmacology (3 papers). C. Villena is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Treatment and Pharmacology (3 papers). C. Villena collaborates with scholars based in Germany and United States. C. Villena's co-authors include M. Funke, Carsten Zwick, Gerhard Seitz, Yao‐Tseng Chen, Ali O. Güre, Özlem Türeci, Uğur Şahin, Michael Pfreundschuh, Lloyd J. Old and Solam Tsang and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Investigational New Drugs.

In The Last Decade

C. Villena

6 papers receiving 222 citations

Peers

C. Villena

MB

IMMUN

RNMI

ONCOL

PRM

Kevin Schifferli United States

Claire Y. Oh United States

Marta Escorihuela Spain

Jessica Da Gama Duarte Australia

Karie Runcie United States

Connor J. Liu United States

Serina Tokita Japan

Annie Borch Denmark

Mahan Moshir Belgium

Joseph Kauer Germany

Kevin Schifferli United States

C. Villena

74 ×0.6

MB

85 ×0.8

IMMUN

69 ×1.0

RNMI

78 ×1.3

ONCOL

16 ×0.5

PRM

Citations per year, relative to C. Villena C. Villena (= 1×) peers Kevin Schifferli

Countries citing papers authored by C. Villena

Since Specialization

Citations

This map shows the geographic impact of C. Villena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Villena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Villena more than expected).

Fields of papers citing papers by C. Villena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Villena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Villena. The network helps show where C. Villena may publish in the future.

Co-authorship network of co-authors of C. Villena

This figure shows the co-authorship network connecting the top 25 collaborators of C. Villena. A scholar is included among the top collaborators of C. Villena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Villena. C. Villena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Hahn, Antje, et al.. (2014). Neoadjuvant chemotherapy for breast cancer with weekly nab-paclitaxel followed by epirubicin and cyclophosphamide--results of a case series.. PubMed. 28(2). 235–41. 4 indexed citations

2.

Funke, M. & C. Villena. (2008). Bildgebende Diagnostik des Mammakarzinoms. Der Radiologe. 48(6). 601–614. 47 indexed citations

3.

Schilling, Georgia, Nadia Harbeck, Christoph Thomssen, et al.. (2008). Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy). Investigational New Drugs. 27(2). 166–172. 13 indexed citations

4.

Wit, Maike de, Nadia Harbeck, Christoph Thomssen, et al.. (2004). Interim results of a prospective, open-label, multicentre phase II trial of the efficacy and safety of vinorelbine (N) and trastuzumab (H) in patients with HER2-positive metastatic breast cancer (MBC). Journal of Clinical Oncology. 22(14_suppl). 831–831. 11 indexed citations

5.

Türeci, Özlem, Yao‐Tseng Chen, Uğur Şahin, et al.. (1998). Expression ofSSX genes in human tumors. International Journal of Cancer. 77(1). 19–23. 152 indexed citations

6.

Villena, C., et al.. (1992). [A clinical evaluation of MAb BW 835/6 in breast and ovarian cancer].. PubMed. 31(6). 249–53. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact